4/17
01:42 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/17
01:42 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/17
01:42 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
4/9
08:09 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
4/9
08:04 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/9
08:04 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/2
11:50 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Guggenheim.
4/2
11:50 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Guggenheim.
4/2
11:44 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/2
11:44 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/2
08:11 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
4/2
07:59 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
4/2
07:59 am
phat
Rating for PHAT
Medium
Report
Rating for PHAT
3/10
01:35 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/10
01:35 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/10
01:35 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/10
11:10 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Craig Hallum.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Craig Hallum.
3/10
11:10 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Craig Hallum.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Craig Hallum.
3/7
08:13 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
High
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/6
02:24 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
3/6
02:06 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
3/6
02:06 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
2/26
06:22 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
High
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
2/14
07:14 am
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
2/14
06:32 am
phat
Phathom Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Medium
Report
Phathom Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald